IM8 raises capital from General Catalyst Customer Value Fund
IM8, a supplements brand, raised capital from General Catalyst Customer Value Fund on Jul 14, 2026. Amount invested is separate from enterprise value.
Preliminary: The deal status, transaction value, value basis and value notes are not yet independently verified.
Transaction summary
- Company
- IM8
- Investor(s)
- General Catalyst Customer Value Fund
- Announced
- 2026-07-14
- Completed
- 2026-07-14
- Geography
- -
- Type
- Capital Raise
- First added
- 2026-08-08
- Latest update
- 2026-11-03
Raise and valuation context
100% enterprise value
USD 1.0B
Unverified
100% enterprise value | USD
Basis: Estimated
Reported price is assumed to be 100% EV unless stated otherwise. Partial-stake estimates are qualified in the basis notes.
EV / revenue
-
Period not stated
Basis: Public source
EV / EBITDA
-
EBITDA basis not stated
Basis: Public source
Amounts paid and other reported values
Original reported amounts and bases; a stake payment is distinct from the estimated whole-company valuation.
Investment Amount: USD 1.0B
Fitt Insider reports that IM8 secured up to $1 billion of non-dilutive, customer-acquisition-linked financing from General Catalyst Customer Value Fund; the amount is described as a maximum commitment rather than a stated funded amount.
Basis
- Estimated investment amount: USD 1.0bn.
Other reviewed estimates
Earlier estimates and their sources.
Source summary
IM8 Lands $1B in Growth Capital.
EstimatedFitt Insider reports that David Beckham-backed supplement company IM8 secured up to $1 billion in non-dilutive financing from General Catalyst Customer Value Fund, tied to customer acquisition and structured without equity dilution.
Open sourceContinue your research
Related transaction comps
Medici Brands raises capital from Greenoaks; Valor Equity Partners; Peter Rahal; Iconiq; Imaginary Ventures
2026-09-02 · Confirmed
View transaction → SupplementsAuNutra Industries acquired by Vivify Specialty Ingredients
2026-10-19 · Confirmed
View transaction → SupplementsSpecnova acquired by HTBA
2026-10-09 · Confirmed
View transaction → SupplementsTwinlab acquired by cbdMD
2026-09-02 · Confirmed
View transaction →